Inhibition of interleukin-2 production by adherent cell factors from lepromatous leprosy patients
- PMID: 6334579
- PMCID: PMC1577108
Inhibition of interleukin-2 production by adherent cell factors from lepromatous leprosy patients
Abstract
Twenty-four hour supernatants (MoF) were obtained from monocyte rich 2 h adherent cells of 19 leprosy patients and four healthy contacts. MoF from borderline and lepromatous patients produced 52-61% inhibition of human interleukin-2 (IL-2) production by a PHA conditioned T cell line (Jurkat). Non-adherent cell supernatants and MoF from tuberculoid and healthy individuals had little effect on IL-2 production. The suppression effected by MoF was in the first 12 h of initiation of PHA stimulated Jurkat cell cultures. Suppressive MoF did not interfere with (1) IL-2 release, (2) IL-2 utilization by Con A-induced T cell blasts or (3) constitutive proliferation of Jurkat cells. Such MoF were released spontaneously from adherent cells of bacilliferous leprosy patients but required in vitro antigen triggering in long term treated lepromatous patients. It is possible that the unresponsiveness associated with lepromatous leprosy is related to the inhibition of IL-2 production by suppressive factors, thereby, preventing the further expansion of antigen reactive T cells.
Similar articles
-
Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.Clin Exp Immunol. 1984 Dec;58(3):522-30. Clin Exp Immunol. 1984. PMID: 6391762 Free PMC article.
-
Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.J Immunol. 1993 May 15;150(10):4641-51. J Immunol. 1993. PMID: 8482851
-
Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.J Immunol. 1985 Aug;135(2):1443-9. J Immunol. 1985. PMID: 2989366
-
In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.Int J Lepr Other Mycobact Dis. 1985 Sep;53(3):385-94. Int J Lepr Other Mycobact Dis. 1985. PMID: 3900245
-
Stigma variations: observations on suppressor T cells and leprosy.Annu Rev Immunol. 1992;10:453-88. doi: 10.1146/annurev.iy.10.040192.002321. Annu Rev Immunol. 1992. PMID: 1534241 Review.
Cited by
-
Regulatory role of FcR+ and FcR- monocyte subsets in Mycobacterium leprae-induced lymphoproliferative response in vitro.Clin Exp Immunol. 1987 Jan;67(1):43-50. Clin Exp Immunol. 1987. PMID: 2957129 Free PMC article.
-
Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.Clin Exp Immunol. 1989 May;76(2):233-9. Clin Exp Immunol. 1989. PMID: 2503276 Free PMC article.
-
Elevated IL-6R on CD4+ T cells promotes IL-6 driven Th17 cell responses in patients with T1R leprosy reactions.Sci Rep. 2020 Sep 15;10(1):15143. doi: 10.1038/s41598-020-72148-7. Sci Rep. 2020. PMID: 32934336 Free PMC article.
-
Interleukin 2 (IL 2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL 2 receptor levels.J Clin Immunol. 1990 Mar;10(2):115-20. doi: 10.1007/BF00918193. J Clin Immunol. 1990. PMID: 2338453
-
Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.J Exp Med. 1987 Jan 1;165(1):239-44. doi: 10.1084/jem.165.1.239. J Exp Med. 1987. PMID: 3540178 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical